- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 243/24 - Oxygen atoms
Patent holdings for IPC class C07D 243/24
Total number of patents in this class: 91
10-year publication summary
|
4
|
4
|
3
|
7
|
5
|
8
|
6
|
9
|
0
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4879 |
18 |
| F. Hoffmann-La Roche AG | 7970 |
4 |
| The Johns Hopkins University | 5561 |
4 |
| Gilead Sciences, Inc. | 1976 |
4 |
| Stemsynergy Therapeutics, Inc. | 18 |
4 |
| Hoffmann-La Roche Inc. | 3307 |
3 |
| Enanta Pharmaceuticals, Inc. | 428 |
3 |
| Lieber Institute, Inc. | 38 |
3 |
| President and Fellows of Harvard College | 5926 |
2 |
| Arrow Therapeutics Limited | 13 |
2 |
| Baruch S. Blumberg Institute | 30 |
2 |
| Nippon Chemiphar Co., Ltd. | 236 |
2 |
| University of Durham | 127 |
2 |
| UWM Research Foundation, Inc. | 152 |
2 |
| Washington University | 1555 |
2 |
| Ayala Pharmaceuticals Inc. | 18 |
2 |
| Novartis AG | 11224 |
1 |
| The Regents of the University of California | 19630 |
1 |
| Genentech, Inc. | 3889 |
1 |
| Bayer AG | 3230 |
1 |
| Other owners | 28 |